Ignite Creation Date:
2025-12-25 @ 1:18 AM
Ignite Modification Date:
2025-12-25 @ 11:26 PM
Study NCT ID:
NCT05664893
Status:
RECRUITING
Last Update Posted:
2025-03-30
First Post:
2022-11-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS)
Sponsor:
Centre Antoine Lacassagne
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-26
Start Date Type:
ACTUAL
Primary Completion Date:
2031-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-03
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-25
First Submit QC Date:
None
Study First Post Date:
2022-12-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-28
Last Update Post Date:
2025-03-30
Last Update Post Date Type:
ACTUAL